PARP1 and diabetes mellitus: As indicated by the Western blot analysis, there was no significant difference in the expression of full-length PARP-1 among the normal control group, diabetes group, and diabetes with nicotinamide treatment group at 4 or 12 weeks after induction of diabetes (p = 0.228, p = 0.103, respectively; Figure 7).